Abivax SA Sponsored ADR

ABVX Healthcare Biotechnology

In the quarter to June 2026, EPS fell 98.8%, free cash flow fell 48.3% and total debt fell 98.5%, each against the same quarter a year earlier.

87.78 4.60 −4.98%
Market cap
$8.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Total current assets
623.68 184.68 309.51 38.12 84.96 44.71 19.19 23.98
Total non-current assets
37.45 37.40 44.47 41.47 — — — —
Total Assets
661.12 222.08 353.98 79.59 125.51 87.24 58.06 61.79
Total current liabilities
71.30 101.72 75.81 33.85 35.85 30.52 17.68 10.92
Total non-current liabilities
74.80 76.44 66.03 38.17 — — — —
Total liabilities
146.10 178.16 141.84 72.02 92.79 81.52 44.84 28.93
Common Equity (Total)
515.02 43.92 212.14 7.57 32.72 5.72 13.22 32.86
Shareholders Equity (Total)
515.02 43.92 212.14 7.57 32.72 5.72 13.22 32.86
Total Debt
2.10 104.09 60.03 41.26 60.78 41.58 23.28 12.46

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Oct 2026